04 November 2025
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025 (Revised)
Read More
04 November 2025
Clarification of significant adjustment to the financial statement for the first quarter of 2025 (Revised as notified by the SEC) (Edited)
Read More
31 October 2025
SET lifts SP sign on NRF's securities and encourages investors to carefully study information of NRF's revised financial statements for Q1/2025 and financial statements for Q2/2025 before making investment decisions
Read More
31 October 2025
Waiver of the right to increase capital in Galalane Limited
Read More
31 October 2025
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025
Read More
30 October 2025
Financial Performance Quarter 2 (F45) (Reviewed)
Read More
30 October 2025
Clarification of significant adjustment to the financial statement for the first quarter of 2025 (Revised as notified by the SEC)
Read More
30 October 2025
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2025 (Revised as notified by the SEC)
Read More
30 October 2025
Financial Performance Quarter 1 (F45) (Reviewed) (Revised)
Read More
30 October 2025
Notification of Resignation of Director and Appointment of Independent Director and Audit Committee Member (Revised News Topic)
Read More
30 October 2025
Notification of Resignation and Appointment of Independent Director and Audit Committee Member
Read More
28 October 2025
Clarification of significant adjustments to the financial statements for the fiscal year 2024 (Revised as notified by the SEC) (Revised)
Read More